TIME is of the essence. Giving HIV-positive infants prompt treatment halves their risk of dying early in childhood. The finding builds on results earlier this year showing that a baby and 14 adults were effectively “cured� by early treatment.
In 2005, Mark Cotton of Stellenbosch University in Cape Town, South Africa, began a study of 377 South African infants aged 6 to 12 months. One-third received no antiretroviral drugs until their immune system showed signs of weakening, in line with standard practice at the time. The others received the drugs at 7 weeks of age, on average. Of these, half were treated for 40 weeks, the others for 96 weeks.
Five years later, 21 “delayers� had died, compared with 11 and nine in the two “early� groups. What’s more, 24 of the infants who had 40 weeks of treatment and 40 that received 96 weeks remain off medication (The Lancet, ).
Advertisement
Current guidelines say babies can have antiretrovirals at 6 weeks of age, but most HIV-positive babies start treatment at 6 months, Cotton says. He hopes the findings will help change that.
This article appeared in print under the headline “Swift treatment helps tots with HIV�